RLX Technology Inc. RLX

Latest FY: 2025 Consumer Defensive Tobacco
Market Price $1.95
Market Cap $3.11B
P/E Ratio 19.50
Quick Peer Compare (Consumer Defensive):
Revenue (FY 2025) ↑50.3% YoY
$566.11M
3-Yr CAGR: -9.9%
Net Income ↑74.4% YoY
$131.83M
Net Margin: 23.3%
Free Cash Flow ↑22.0% YoY
$141.11M
FCF Yield: 4.53%
EPS (Diluted) ↑69.5% YoY
$0.10
Basic: $0.10
Return on Equity Efficiency
5.9%
ROA: 0.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (RLX)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $42.7M $7.2M $-40.9M $-7.23 $-0.3M $-0.5M
FY 2017 $60.1M +40.5% $16.0M $-31.2M +23.7% $-4.90 +32.2% $-7.4M $-8.0M -1,618.2%
FY 2018 $132.6M +120.8% $59.2M $-45.4M -45.4% $-0.00 +100.0% $-1.0M $-1.0M +87.5%
FY 2019 $1,549.4M +1,068.3% $580.9M $47.7M +205.2% $0.03 +16,600.0% $338.1M $253.2M +25,265.0%
FY 2020 $585.4M -62.2% $234.1M $-19.6M -141.1% $-0.01 -142.4% $396.8M $394.9M +56.0%
FY 2021 $1,337.1M +128.4% $576.2M $317.7M +1,718.5% $0.23 +1,707.1% $282.4M $261.9M -33.7%
FY 2022 $773.2M -42.2% $334.2M $209.0M -34.2% $0.16 -30.2% $70.6M $65.0M -75.2%
FY 2023 $223.4M -71.1% $54.6M $75.3M -64.0% $0.06 -64.3% $28.0M $24.0M -63.0%
FY 2024 $376.6M +68.5% $99.5M $75.6M +0.5% $0.06 +5.4% $117.0M $115.7M +381.7%
FY 2025 $566.1M +50.3% $169.3M $131.8M +74.4% $0.10 +69.5% $157.9M $141.1M +22.0%
$

Valuation

Market Price $1.95
Market Cap $3.11B
Enterprise Value N/A
P/E Ratio 19.50
P/B Ratio 1.35
FCF Yield 4.53%
Dividend Yield 5.64%
Shares Outstanding 1,548,940,307
%

Profitability & Margins

Gross Margin 29.90%
Operating Margin 8.30%
Net Margin 23.29%
Return on Equity (ROE) 5.90%
Return on Assets (ROA) 0.74%
Asset Turnover 0.03x
Revenue 3-Yr CAGR -9.87%
🛡️

Financial Health & Liquidity

Current Ratio 1.60
Cash Ratio 26.85
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $767.49M
Total Debt N/A
Book Value / Share $1.44
💧

Cash Flow Efficiency

Operating Cash Flow $157.95M
Capital Expenditures (CapEx) $16.84M
Free Cash Flow $141.11M
OCF / Revenue 27.90%
FCF / Revenue 24.93%
FCF 3-Yr CAGR 29.50%
🏷️

Per Share Metrics

EPS (Diluted) $0.10
EPS (Basic) $0.10
Dividends / Share $0.11
Book Value / Share $1.44
EPS YoY Growth 69.49%
🏛️

Balance Sheet (FY 2025)

Total Assets $17.93B
Total Liabilities $2.20B
Stockholders' Equity $2.24B
Current Assets $45.69M
Current Liabilities $28.59M